2m 2m 2m 2m 2m 2m 2m
PROTARA THERAPEU (TARA)
NASDAQ
$3.96+$0.04 (+0.92%)
Price as of Aug 03, 2026 10:20 AM EDT- $220.3MMarket Cap
- 28.10%1-Year Change
- BiotechnologyIndustry
PROTARA THERAPEU (TARA)
$3.96+$0.04 (+0.92%)
TARA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.92 | ||
Change | -$0.11 (-2.73%) | ||
Open | $4.00 | ||
High | $4.04 | ||
Low | $3.81 | ||
Previous Close | $4.03 | ||
Volume | 294,633 | ||
30-Day Average Volume | 530,019 | ||
1-Week Change | -2.49% | ||
1-Month Change | 2.62% | ||
1-Year Change | 28.10% | ||
3-Year Change | 51.35% | ||
5-Year Change | -50.57% | ||
Fundamentals | |||
Shares Outstanding | 56.2M | ||
Total Assets | $191.9M | ||
Market Cap | $220.3M | ||
Enterprise Value | $205.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$17.8M | ||
Free Cash Flow | -$21.3M | ||
EBIT | -$17.8M | ||
EBITDA | -$17.7M | ||
Net Working Capital | $131.1M | ||
EPS | -$0.31 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -13 | ||
PEG | -1 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue